miglustat has been researched along with Inflammation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Aureli, M; Bassi, R; Bragonzi, A; Cabrini, G; D'Alonzo, D; De Fenza, M; De Fino, I; Dechecchi, MC; Esposito, A; Gambari, R; Guaragna, A; Lampronti, I; Lippi, G; Loberto, N; Munari, S; Palumbo, G; Ranucci, S; Rossi, A; Santangelo, A; Tamanini, A; Tironi, M | 1 |
| Donida, B; Dos Reis, BG; Faverzani, JL; Hammerschmidt, TG; Kessler, RG; Machado, AZ; Moura, AP; Moura, DJ; Reinhardt, LS; Sebastião, FM; Vargas, CR | 1 |
| D'Alonzo, D; Dechecchi, MC; Esposito, A; Fenza, M; Gregorio, E; Guaragna, A; Lippi, G; Tamanini, A | 1 |
| Blank, PS; Cluzeau, CV; Cologna, SM; Dail, MK; Lieberman, AP; Porter, FD; Siebel, S; Toth, CL; Wassif, CA; Yanjanin, NM | 1 |
| Hughes, DA; Mehta, A; Thomas, AS | 1 |
| Aureli, M; Bassi, R; Bezzerri, V; Cabrini, G; Cantù, C; Cavazzini, A; Cheng, SH; Dechecchi, MC; Gambari, R; Giri, MG; Lampronti, I; Loberto, N; Lovato, V; Marchetti, N; Munari, S; Sonnino, S; Tebon, M | 1 |
| Butters, TD; d'Azzo, A; Dwek, RA; Elliot-Smith, E; Jeyakumar, M; Perry, VH; Platt, FM; Smith, DA; Thomas, R; van der Spoel, AC | 1 |
2 review(s) available for miglustat and Inflammation
| Article | Year |
|---|---|
Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.
Topics: 1-Deoxynojirimycin; Anti-Inflammatory Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Glycoside Hydrolases; Glycosyltransferases; Heterocyclic Compounds, 1-Ring; Humans; Imino Pyranoses; Inflammation; Molecular Structure; Mutation; Sequence Deletion; Tartrates | 2020 |
Gaucher disease: haematological presentations and complications.
Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response | 2014 |
5 other study(ies) available for miglustat and Inflammation
| Article | Year |
|---|---|
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; beta-Glucosidase; Bronchi; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Imino Sugars; Inflammation; Inhibitory Concentration 50; Mice; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Stereoisomerism | 2019 |
Cytokine profile and cholesterol levels in patients with Niemann-Pick type C disease presenting neurological symptoms: in vivo effect of miglustat and in vitro effect of N-acetylcysteine and coenzyme Q10.
Topics: 1-Deoxynojirimycin; Acetylcysteine; Antioxidants; Cholesterol; Cytokines; Enzyme Inhibitors; Humans; Inflammation; Niemann-Pick Disease, Type C; Ubiquinone | 2022 |
Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1.
Topics: 1-Deoxynojirimycin; Adolescent; Alleles; Animals; Biomarkers; Brain; Cerebellum; Cerebral Cortex; Chemokine CCL3; Chemokine CXCL5; Child; Child, Preschool; Complement C3; Disease Models, Animal; Female; Gene Expression Regulation; Humans; Infant; Infant, Newborn; Inflammation; Interleukins; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Niemann-Pick Disease, Type C; Young Adult | 2014 |
GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa.
Topics: 1-Deoxynojirimycin; beta-Glucosidase; Bronchi; Cystic Fibrosis; Epithelial Cells; Glucosylceramidase; Glycoside Hydrolase Inhibitors; Humans; Inflammation; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
Topics: 1-Deoxynojirimycin; Animals; Antigens, CD; Apoptosis; Biomarkers; Blood-Brain Barrier; Cytokines; Enzyme Inhibitors; Gangliosidoses; Gangliosidoses, GM2; Gangliosidosis, GM1; Genes, MHC Class II; Immunohistochemistry; Inflammation; Mice; Sandhoff Disease; Tay-Sachs Disease | 2003 |